FDA.reportPublic FDA data

cytarabine 100 MG / daunorubicin 44 MG Liposome Injection

RxCUI
1942743
RxNorm name
cytarabine 100 MG / daunorubicin 44 MG Liposome Injection
Display name
cytarabine 100 MG / daunorubicin 44 MG Liposome Injection
Full name
cytarabine 100 MG / daunorubicin 44 MG Liposome Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VYXEOS(DAUNORUBICIN AND CYTARABINE) LIPOSOMEJazz Pharmaceuticals, Inc.7ea701ce-e7d3-4349-a9c2-642a501d45c82026-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1942743

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ea701ce-e7d3-4349-a9c2-642a501d45c8cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection [PSN] · cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [SCD] · ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection [SY] · cytarabine 100 MG / daunorubicin 44 MG Liposome Injection [SY]414These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 201720260130